Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation

Open Access
Publisher Website
Google Scholar
Abstract
No abstract available
Funding Information
  • National Cancer Institute (U24-CA076518)
  • National Heart, Lung and Blood Institute (NHLBI)
  • National Institute of Allergy and Infectious Diseases
  • NHLBI (5U10HL069294)
  • NCI
  • Health Resources and Services Administration
  • Office of Naval Research (N00014-12-1-0142, N00014-13-1-0039)
  • Actinium Pharmaceuticals
  • Amgen, Inc.
  • Anonymous donation to the Medical College of Wisconsin
  • Ariad; Be the Match Foundation
  • Blue Cross and Blue Shield Association
  • Celgene Corporation; Chimerix, Inc.
  • Fred Hutchinson Cancer Research Center; Fresenius-Biotech North America, Inc.
  • Gamida Cell Teva Joint Venture Ltd.
  • Genentech, Inc.
  • Gentium SpA
  • Genzyme Corporation
  • GlaxoSmithKline
  • Health Research, Inc.
  • Roswell Park Cancer Institute
  • HistoGenetics, Inc.
  • Incyte Corporation
  • Jeff Gordon Children's Foundation
  • Kiadis Pharma
  • The Leukemia & Lymphoma Society
  • Medac GmbH
  • The Medical College of Wisconsin
  • Merck & Co., Inc.
  • The Takeda Oncology Co.
  • Milliman USA, Inc.
  • Miltenyi Biotec, Inc.
  • National Marrow Donor Program
  • Onyx Pharmaceuticals
  • Optum Healthcare Solutions, Inc.
  • Osiris Therapeutics, Inc.
  • Otsuka America Pharmaceutical, Inc.
  • Perkin Elmer, Inc.
  • Remedy Informatics
  • Sanofi US
  • Seattle Genetics
  • Sigma-Tau Pharmaceuticals
  • Soligenix, Inc.
  • St. Baldrick's Foundation
  • A Global Cord Blood Therapeutics Co.
  • Stemsoft Software, Inc.
  • Swedish Orphan Biovitrum
  • Tarix Pharmaceuticals
  • Terumo BCT
  • Teva Neuroscience, Inc.
  • Texas Instruments Inc.
  • University of Minnesota
  • University of Utah
  • WellPoint , Inc.